Hong Kong May Lower BioNTech Vaccine Age To 12
"); jQuery("#212 h3").html("
"); });
2021-06-02 HKT 00:38
Share this story
The Department of Health on Tuesday said it had received an application from Fosun Pharma on Saturday to lower the minimum age for the Comirnaty vaccine to 12, along with phase three clinical trial data.
It said the information had been passed on to the advisory panel on Covid-19 vaccines and that the secretary for food and health would consider any suggestions.
The department said it expected a decision could be reached quickly.
The minimum age for the Comirnaty vaccine, provided by BioNTech and its Greater China partner Fosun Pharma, is 16 in the SAR.
The minimum age for the other vaccine used in Hong Kong, which is made by Sinovac, is 18.
Five Years In: Lessons From Asias Digital Bank Revolution | David Becker, MD APAC, Mambu
Digital banking in Asia was supposed to change the world. Five years later, did it live up to the hype? In this in-dept... Read more
19th Asian Financial Forum To Spotlight Finance And Global Opportunities
The 19th Asian Financial Forum (AFF), co-organised by the Hong Kong SAR government and the Hong Kong Trade Development ... Read more
HK Banks Launch Money Safe Service To Protect Deposits
The Hong Kong Monetary Authority (HKMA) and the Hong Kong Association of Banks (HKAB) announced on 30 December that all... Read more
HashKey Lists On Hong Kong Exchange
HashKey listed on the Main Board of The Stock Exchange of Hong Kong Limited, becoming the first digital asset company t... Read more
North Korea Linked To Over Half Of 2025 Crypto Heist Losses
TRM has published new research showing that North Korea-linked actors were responsible for more than half of the US$2.7... Read more
South Korea Forms Task Force After Coupang Data Breach
The South Korean government announced on Thursday (19 December) that it will establish an interagency task force to add... Read more